email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
931 - 945
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Innovent Says China Trial Started for Claudin 18.2 CAR-T Cell Therapy
$5.00
Available
Revotek Starts Trial of Stem Cell 3D Printing Product for Arterial Disease
$5.00
Available
TransThera to Start US Trials of Novel BTK Inhibitor
$5.00
Available
Legend Halts US Trial of CD4+ CAR-T after First Patient Dosed
$5.00
Available
Innovent Reports PCSK-9 mAb Meets Endpoint in Hypercholesterolemia Trials
$5.00
Available
Gracell's BCMA/CD19 CAR-T Starts China Trial for Non-Hodgkin's Lymphoma
$5.00
Available
Sirnaomics Ok'd to Start US Trials of siRNA Therapy for Rare Disease
$5.00
Available
SciNeuro Teams Up with Alamar to Discover Novel CNS Drugs
$5.00
Available
AffaMed In-licenses Rights to AMD Therapy, Approved to Start US Trials
$5.00
Available
IASO/Innovent BCMA CAR-T Granted US Orphan Status for Myeloma
$5.00
Available
CStone Approved to Market Precision Medicine Drug for AML Patients
$5.00
Available
Everest Approved to Launch Triple-Negative Breast Cancer ADC in Singapore
$5.00
Available
Innovent/Lilly PD-1 Rejected by US FDA Panel; Lilly Says Price 40% Below Competition
$5.00
Available
Zerun Bio Lands CEPI Grant to Start Trials of Multi-Variant COVID Vaccine
$5.00
Available
Innovent/Lilly Face US FDA Setback Due to China-Only PD-1 Trials
$5.00
Available